The use of opioids alone does not significantly impair cognition in patients with HIV infection, but the combined use of opioids and antidepressants is linked to poorer neurocognitive performance.

With an increasing number of longer-term survivors treated with chimeric antigen receptor (CAR) T-cell therapy for non-Hodgkin lymphoma (NHL), more research is needed to confirm its effects on ...

Please provide your email address to receive an email when new articles are posted on . Survivors of childhood cancer are at risk for neurocognitive decline later in life related to the disease and ...

Despite its recognition for centuries as “the great imitator,” neurosyphilis remains a diagnostic challenge because of its wide spectrum of presentations. Here we describe 3 men with neurosyphilis in ...

Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...

Human brain, illustration. As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed ...

Nevertheless, donepezil (10 mg per day) demonstrated a statistically significant benefit for this population with respect to memory, motor speed, and dexterity after 24 weeks of drug administration ...

According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of ...

Abbreviations: AeYA, adolescent and early young adult; NA, not applicable; SMN, second malignant neoplasm. Comparing AeYA survivors with non-AeYA survivors. Comparing AeYA survivors with siblings.

Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...